News and Media

Nocturnal Light Saves Sight – The Ophthalmologist

Today’s treatment of DME and wet AMD is invasive, costly, inconvenient, and hospital-based. The sleep mask is noninvasive, dramatically less expensive than chronic anti-VEGF treatment regimens, and will help allow patients to take charge of their own treatment at home, under the care of their physicians. If it lives up to the promise already shown in clinical trials, Noctura could profoundly change the future
management of diabetic eye disease and wet AMD.

Read full article on page 33 of The Ophthalmologist now →